FINANCIAL STATEMENT ANALYSIS

USED BY US DEPARTMEN OF EDUCATION, UNIVERSITIES, STUDENTS & ACCOUNTING PRO'S

VentureLine tracks and provides 5-year financial statement analysis on approximately 7,000+ publicly traded companies; the SEC-traceable data is updated weekly. For your convenience you can access that current company financial statement analysis information by clicking directly on the Company Name, visit their Website or enter the Company name or Ticker symbol, e.g. enter 'Microsoft' or 'MSFT' for Microsoft, in the Company Search window below.

FINANCIAL STATEMENT ANALYSIS UPDATED: JULY 24, 2022

Results 251 through 263 of 263

- SIC # 2830

Ticker Exchange Company Financial Reports SIC #
VRNO Over the counter Verano Holdings Corp. 2830
VTGN Nasdaq Vistagen Therapeutics, Inc. 2830
WVE Nasdaq Wave Life Sciences, Inc. 2830
XAIR Nasdaq Beyond Air, Inc. 2830
XBIO Nasdaq Xenetic Biosciences, Inc. 2830
XBIT Nasdaq XBiotech Inc. 2830
XCUR Nasdaq Exicure, Inc. 2830
XENE Nasdaq Xenon Pharmaceuticals Inc. 2830
XERS Nasdaq Xeris Biopharma Holdings, Inc. 2830
XNCR Nasdaq Xencor, Inc. 2830
XRTX Nasdaq XORTX Therapeutics Inc. 2830
YARW Nasdaq Yarrow Bioscience, Inc. 2830
ZYBT Nasdaq Zhengye Biotechnology Holding Limited 2830
Results 250 through 263 of 263